Cesca Therapeutics Inc.

Cesca Therapeutics Inc. is a fully integrated regenerative medicine company that combines cell-therapy-related devices, patented platform technology, and proprietary cell formulations and treatment protocols for the development of commercializable cell therapies. Cesca will offer safe and effective therapies backed by clinical evidence, including eight clinical trials in critical limb ischemia, acute myocardial infarction, osteoarthritis and avascular necrosis, among others, using patient and regulator friendly autologous cells and at the bedside, 60-90 minute protocol.